G., & Prvu, M
I have two testimonies I want to share: one focuses on pain relief through regenerative medicine, and the other highlights my weight loss journey supported by hormone therapy
No orals before the injectable GLP-1s had this kind of benefit in cardiovascular outcomes trials, she says
These typically include: Nausea, especially after eating large meals Reduced appetite, which is partly how the medication works Occasional digestive discomfort during the adjustment period Changes in bowel habits Most of these symptoms improve as your body adjusts to the medication
While gastrointestinal AEs such as nausea and vomiting dominate safety reports 8 and recent pharmacovigilance studies highlight increasingly recognized risks including acute pancreatitis, nephritis, hypotension, and syncope 9,10,11 , emerging data suggest that GLP-1 RAs may be associated with neurological adverse events (NAEs) 12,13
Lauderdale, FL 33309.